Search Results - "Arduc, A."

Increased Risk of Unfavorable Metabolic Outcome in Patients with Clinically Nonfunctioning Pituitary Adenomas by Doğan, B A, Tuna, M M, Arduç, A, Başaran, M N, Küçükler, K, Dağdelen, I, Berker, D, Güler, S

“…The aim of this study was to investigate atherosclerotic risk markers in women with clinically nonfunctioning pituitary adenomas (CNFAs). Records of 47 women…”
Get more information

Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience by Arduc, A., Gokay, F., Isik, S., Ozuguz, U., Akbaba, G., Tutuncu, Y., Berker, D., Kucukler, F. K., Aydin, Y., Guler, S.

“…Introduction Patients with hyperprolactinemia who require medical therapy are typically treated with dopamine agonists (DAs). In most cases, DAs normalize…”
Get full text

621P The rarest subtype of a rare disease: infantile facioscapulohumeral dystrophy by Yunisova, G., Akçay, A. Arduç, Eraslan, S., Avci, Ş, Eren, İ, Acarli, A. Özdağ, Kayserili, H., Oflazer, P.

“…Facioscapulohumeral dystrophy (FSHD) is the third most common hereditary muscular dystrophy with an autosomal dominant inheritance. The disease is associated…”
Get full text

ATHEROSCLEROSIS RISK IN SUBCLINIC HYPOTHYROIDISM by Berker, D., Ozkan, B., Aydin, Y., Arduc, A., Cakir, E., Delibasi, T., Eskioglu, E., Guler, S.

Get full text

EVALUATION OF ATHEROSCLEROTIC RISK FACTORS AND CAROTIS INTIMA MEDIA THICKNESS IN HEALTHY OFFSPRING OF TYPE 2 DIABETIC PATIENTS by Aydin, Y., Arduc, A., Berker, D., Yilmaz, M., Delibasi, T., Beyan Unlu, E., Guler, S., Abayli, E.

Get full text